EX-2.1
from 8-K
110 pages
Agreement and Plan of Merger by and Among BiomX Inc., a Delaware Corporation; Btx Merger Sub I, Inc., a Delaware Corporation; Btx Merger Sub II, LLC, a Delaware Limited Liability Company; and Adaptive Phage Therapeutics, Inc., a Delaware Corporation Dated as of March 6, 2024
12/34/56
EX-2.1
from DEFA14A
77 pages
Merger Agreement Dated July 16, 2019 by and Among BiomX Ltd., an Israeli Company (The “Company”), Shareholder Representative Services LLC, as the Shareholders’ Representative (The “Shareholders’ Representative”), Chardan Healthcare Acquisition Corp., a Delaware Corporation (The “Purchaser”), and CHAC Merger Sub Ltd., an Israeli Company
12/34/56
EX-2.1
from 8-K
77 pages
Merger Agreement Dated July 16, 2019 by and Among BiomX Ltd., an Israeli Company (The “Company”), Shareholder Representative Services LLC, as the Shareholders’ Representative (The “Shareholders’ Representative”), Chardan Healthcare Acquisition Corp., a Delaware Corporation (The “Purchaser”), and CHAC Merger Sub Ltd., an Israeli Company
12/34/56
